Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats: their relation to ovarian nitroreductive biotransformation of both drugs.
Chagas' disease is a parasitic chronic condition affecting several million people in Latin America. Two drugs are used in the chemotherapy of Chagas' disease: nifurtimox (Nfx) and benznidazole (Bz). Both are nitroderivatives whose deleterious effects are related to their reductive biotransformation. In this work we report that rat ovaries exhibited Bz and Nfx nitroreductase activity. The Bz nitroreductase was only found in the mitochondrial fraction and was partially inhibited by CO. The Nfx nitroreductase activity was maximal in ovarian mitochondria but was also present in microsomes and in the cytosol. The microsomal enzyme was completely inhibited by CO while that in mitochondria was only partially inhibited by CO. The cytosolic activity only proceeded using hypoxanthine as substrate and was inhibited by allopurinol. The cytosolic activity was able to proceed in part under oxygen. All the other Bz or Nfx nitroreductases were completely inhibited by atmospheric oxygen. The potential participation of cytochrome P450, flavoenzymes, iron-sulfur-protein, and xanthinooxidase in both nitroreductive processes is discussed. The administration of either Nfx or Bz to female rats produced ultrastructural degenerative effects in the different cell types of ovaries. Specific alterations such as swelling, disruption, disorganization, and loss of matrix components were observed in ovarian mitochondria. These alterations occurred irrespectively of the ovarian cycle stage. The potential reproductive toxicological consequences of Bz or Nfx administration are analyzed.
de Castro
C R
CR
Centro de Investigaciones Toxicológicas (CEITOX), CITEFA/CONICET, Buenos Aires, Argentina.
de Toranzo
E G
EG
Bernacchi
A S
AS
Carbone
M
M
Castro
J A
JA
D000818:Animals; D001711:Biotransformation; D003600:Cytosol / Q000201:enzymology; D005260:Female; D008854:Microscopy, Electron; D008861:Microsomes / Q000201:enzymology; D008928:Mitochondria / Q000201:enzymology; D009547:Nifurtimox / Q000493:pharmacokinetics / Q000633:toxicity*; D009581:Nitrofurans / Q000633:toxicity*; D009593:Nitroimidazoles / Q000493:pharmacokinetics / Q000633:toxicity*; D009601:Nitroreductases / Q000378:metabolism*; D010053:Ovary / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000648:ultrastructure; D010088:Oxidoreductases / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D014344:Trypanocidal Agents / Q000493:pharmacokinetics / Q000633:toxicity*
D009581:Nitrofurans; D009593:Nitroimidazoles; D014344:Trypanocidal Agents; D010088:Oxidoreductases; D009601:Nitroreductases; D009547:Nifurtimox; C009999:benzonidazole